INVESTOR DEADLINE: Enochian Biosciences Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – ENOB
- Saturday, July 30, 2022, 7:10
- PR Newswire
- Add a comment
SAN DIEGO, July 29, 2022 /PRNewswire/ — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Enochian Biosciences Inc. (NASDAQ: ENOB) securities between January 17, 2018 and June 27, 2022, inclusive (the “Class Period”) have until September 26, 2022 to seek…
About the Author
admin has written 20650 stories on this site.